2-Pfizer-3-4-21
Welcome to our virtual exhibit booth! |
|||
|
|
|||
About UsAt Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 23 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma. |
|||
|
|
|||
Click the graphic below for more information. |
|||
 |
|||
Questions? Join us on Zoom at 7 pmTopic: Ibrance/Talzenna/Trazimera |
|||
|
|
|
||
Contact Us |
|||
| April Bryant | |||
| Oncology Account Specialist (Ibrance/Talzenna) | |||
| april.bryant@pfizer.com | |||
| (703) 304-7135 | |||
|
|
|||
| Heather Riley-Cline | |||
| Oncology Account Specialist (Trazimera) | |||
| heather.riley-cline@pfizer.com | |||
| (540) 931-2348 | |||
